Codice QR

Efficacy and Safety Evaluation of Intrathecal Pemetrexed in EGFR-mutated NSCLC Patients 
with Leptomeningeal Metastases

Background and objective The incidence of leptomeningeal metastasis (LM) in patients with advanced non-small cell lung cancer (NSCLC) is increasing gradually. However, it poses therapeutic challenges due to limited effective interventions. Intrathecal Pemetrexed (IP) holds broad application prospect...

Descrizione completa

Salvato in:
Autori principali: Tianli ZHANG, Xin CHEN, Cheng JIANG, Yongjuan LIN, Yu XIE, Huiying LI, Zhenyu YIN, Tingting YU
Natura: Artigo
Lingua:Chinês
Pubblicazione: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2025-08-01
Serie:Chinese Journal of Lung Cancer
Soggetti:
lung neoplasms
leptomeningeal metastasis
epidermal growth factor receptor
intrathecal chemotherapy
pemetrexed
Accesso online:http://dx.doi.org/10.3779/j.issn.1009-3419.2025.106.23
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi